FDI in pharma jumps to $1.25 billion during April -November period


Although the DIPP had proposed tightening of norms for foreign investors in existing Indian pharmaceutical companies, the Union Cabinet rejected the proposal.NEW DELHI: Foreign direct investment in the pharma sector has more than doubled to $1.25 billion during April-November period of the fiscal even amid concerns about the spate of acquisitions of domestic firms by MNCs.

FDI in drugs and pharmaceuticals was $581 million during April-November 2012, according to the latest data of the Department of Industrial Policy and Promotion (DIPP).

Although the DIPP had proposed tightening of norms for foreign investors in existing Indian pharmaceutical companies, including reducing the FDI cap to 49 per cent in critical verticals from 100 per cent, the Union Cabinet rejected the proposal.  Read More

Source: http://economictimes.indiatimes.com/

Advertisements

Tagged as: , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Categorised in: Pharma & Healthcare, Sector News

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: